Regulatory tracker: Astellas' gastric cancer med Vyloy picks up EU nod
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Friday, September 20 at …